Researchers are discovering new applications for GLP-1 agonist drugs, such as Mounjaro and Ozempic, with recent studies exploring their use in treating substance abuse. This highlights the growing versatility of these medications.

Every other month, researchers find new uses for GLP-1 agonist drugs, like Mounjaro and Ozempic — now even as a treatment for substance abuse. It's classic drug repurposing, a technique that saved lives during COVID.